Katrine Bosley

Katrine Bosley is a biotechnology executive with two decades of industry leadership experience across a spectrum of key corporate and strategic functions. Prior to joining Avila, Katrine Bosley served as Vice President, Business Development and later as VP, Strategic Operations at Adnexus, establishing an alliance with and subsequent acquisition by Bristol-Myers Squibb. During her career she has worked with products from discovery through commercialization, including Avonex®, Tysabri® and the emerging Adnectin™ class of targeted biologics. Katrine Bosley was with Biogen Idec for many years where she held leadership roles in business development, commercial operations and portfolio strategy in both the U.S. and Europe. She also held positions at Highland Capital Partners, a venture capital firm, and Alkermes, a leading biotechnology company. Katrine Bosley is a graduate of Cornell University.